|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBSCO_on1083466785 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
190126s2018 nyu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d N$T
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1082356434
|a 1082543381
|a 1082961958
|a 1089483091
|
| 020 |
|
|
|a 9781536144888
|
| 020 |
|
|
|a 1536144886
|
| 020 |
|
|
|z 1536144878
|
| 020 |
|
|
|z 9781536144871
|
| 035 |
|
|
|a (OCoLC)1083466785
|z (OCoLC)1082356434
|z (OCoLC)1082543381
|z (OCoLC)1082961958
|z (OCoLC)1089483091
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a HV5825
|
| 072 |
|
7 |
|a POL
|x 027000
|2 bisacsh
|
| 072 |
|
7 |
|a POL
|x 019000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 362.290973
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Daniels, Lance.
|
| 245 |
1 |
0 |
|a Drug Abuse
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers, Incorporated,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (277 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Alcohol and Drug Abuse Ser.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro; Contents; Preface; Chapter 1; Opioid Treatment Programs and Related Federal Regulations(; Summary; Medication-Assisted Treatment (MAT); Methadone; Buprenorphine; Naltrexone; Regulatory Framework; Federal Food, Drug, and Cosmetic Act (FFDCA); Controlled Substances Act (CSA); Opioid Treatment Programs (OTPs); OTP Accreditation; OTP Certification; OTP Registration; DATA-Waived Providers (DWPs); Practitioner Requirements; Medication Requirements; Chapter 2; Increase in Illicit Fentanyl Overdose Deaths*; Summary; What Is Fentanyl?; Rise of Fentanyl Overdoses; Availability of Fentanyl
|
| 505 |
8 |
|
|a Policy ConsiderationsChapter 3; The Opioid Epidemic and the Food and Drug Administration: Legal Authorities and Recent Agency Action(; Summary; FDA Approval of Prescription Drugs and the Challenges of Opioids; FDA Authority and Recent Agency Action Related to the Opioid Epidemic; Decreasing Exposure and Preventing New Addiction; Supporting the Treatment of Those with Opioid Use Disorder; Fostering the Development of Novel Pain Treatment Therapies; Improving Enforcement and Assessing Benefit Risk; Selected Opioid-Related Bills in the 115th Congress That Would Amend the FD & C Act; Chapter 4
|
| 505 |
8 |
|
|a High Intensity Drug Trafficking Areas (HIDTA) Program(Summary; HIDTA Designations; Coordination; Funding; HIDTA Issues for Consideration; Unit of Inclusion; County-Level Drug Trafficking Data; Criteria for Inclusion; Program Effectiveness; Program Scope; Use of Funds for Treatment and Prevention Initiatives; Heroin Response Strategy; HIDTA as an ONDCP Component; Chapter 5; Legal Authorities Under the Controlled Substances Act to Combat the Opioid Crisis(; Summary; Brief Background on the Opioid Epidemic; Overview of the CSA; Scheduling of Controlled Substances
|
| 505 |
8 |
|
|a Emergency or Temporary SchedulingScheduling in Order to Satisfy International Treaty Obligations; Who Must Register with the DEA?; Exceptions to the Registration Requirement; Regulatory Obligations of Registrants Under the CSA; Recordkeeping; Security Measures; Reporting; Quotas; Prescription Requirements; Practitioners; Pharmacists; What Are the Potential Consequences for Violating the CSA?; State Regulation of Controlled Substances; DEA's Legal Authorities for Enforcing the CSA; Investigations; Enforcement Actions; Letter of Admonition or Informal Hearing
|
| 505 |
8 |
|
|a Administrative Proceedings to Deny, Revoke, or Suspend a RegistrationImmediate Suspension Orders; Responding to the Opioid Abuse Crisis: DEA Actions and Amendments to the CSA; DEA Actions Against Registrants; Emergency Scheduling of Illicit Fentanyl; Expanding Disposal Options for Unwanted Opioid Medication; CARA and Medication-Assisted Treatment for Opioid Addiction; Aggregate Production Quotas for Certain Schedule II Opioids; Selected Opioid-Related Bills in the 115th Congress That Propose Amending the CSA; Chapter 6; Federal Support for Drug Courts: In Brief*; Summary; Introduction
|
| 500 |
|
|
|a What Are Drug Courts?
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Drug abuse
|z United States.
|
| 650 |
|
6 |
|a Toxicomanie
|z États-Unis.
|
| 650 |
|
7 |
|a POLITICAL SCIENCE
|x Public Policy
|x Social Security.
|2 bisacsh
|
| 650 |
|
7 |
|a POLITICAL SCIENCE
|x Public Policy
|x Social Services & Welfare.
|2 bisacsh
|
| 650 |
|
7 |
|a Drug abuse
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|
| 776 |
0 |
8 |
|i Print version:
|a Daniels, Lance.
|t Drug Abuse: Trends, Issues and Management.
|d New York : Nova Science Publishers, Incorporated, ©2018
|z 9781536144871
|
| 830 |
|
0 |
|a Alcohol and Drug Abuse Ser.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2000537
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5633694
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2000537
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15978441
|
| 994 |
|
|
|a 92
|b IZTAP
|
